U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07555925) titled 'RELIEVE METAB Study' on April 22.
Brief Summary: This prospective, single-center post-market-follow-up study aims to fill knowledge gaps by combining advanced cardiac MRI/MRS with systemic mitochondrial assays and exercise testing to characterize the energetic and functional impact of IASD therapy in HFrEF patients.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Heart Failure With Reduced Ejection Fraction (HFrEF)
Intervention:
OTHER: cardiac MRI
Cardiac Imaging: Multiparametric cardiac MRI (cMRI) and Phosphorus-31 Magnetic Resonance Spectroscopy (³¹P-MRS) at rest and during cycle ergometry to eval...